Michael McClain

Michael McClain is Abcuro’s Clinical Trial Manager. He received his Bachelor of Science in Pharmaceutical Chemistry at UC Davis and his Doctor of Pharmacy at University of the Pacific. Additionally, he is currently in the last year of his MBA Program at Golden Gate University. Following pharmacy school, he started his career in the biopharmaceutical industry at BioMarin Pharmaceuticals working in the rare disease hemophilia area and transitioned to Gilead Sciences where he has worked in the inflammation IBD and early phase oncology area for the past two years. Michael has also been active in leading employee resource groups and managing PharmD internship and fellowship programs over the past several years of his career.